677 related articles for article (PubMed ID: 30095969)
1. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
[TBL] [Abstract][Full Text] [Related]
2. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
3. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
4. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria "THE" target of myocardial conditioning.
Boengler K; Lochnit G; Schulz R
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
[TBL] [Abstract][Full Text] [Related]
7. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
[TBL] [Abstract][Full Text] [Related]
8. The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species.
Stroethoff M; Goetze L; Torregroza C; Bunte S; Raupach A; Heinen A; Mathes A; Hollmann MW; Huhn R
Cardiovasc Drugs Ther; 2020 Jun; 34(3):303-310. PubMed ID: 32236860
[TBL] [Abstract][Full Text] [Related]
9. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and Nicotinamide Mononucleotide Attenuate Myocardial Ischemia/Reperfusion Injury via Modulation of Mitochondrial Function and Hemodynamic Parameters in Aged Rats.
Hosseini L; Vafaee MS; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):240-250. PubMed ID: 31645107
[TBL] [Abstract][Full Text] [Related]
12. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
Lahnwong C; Palee S; Apaijai N; Sriwichaiin S; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
Cardiovasc Diabetol; 2020 Jun; 19(1):91. PubMed ID: 32539724
[TBL] [Abstract][Full Text] [Related]
13. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials.
Wang J; Toan S; Zhou H
Pharmacol Res; 2020 Jun; 156():104771. PubMed ID: 32234339
[TBL] [Abstract][Full Text] [Related]
15. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
Hall AR; Burke N; Dongworth RK; Kalkhoran SB; Dyson A; Vicencio JM; Dorn GW; Yellon DM; Hausenloy DJ
Cell Death Dis; 2016 May; 7(5):e2238. PubMed ID: 27228353
[TBL] [Abstract][Full Text] [Related]
16. Hongjingtian injection protects against myocardial ischemia reperfusion-induced apoptosis by blocking ROS induced autophagic- flux.
Zhao J; Zhang J; Liu Q; Wang Y; Jin Y; Yang Y; Ni C; Zhang L
Biomed Pharmacother; 2021 Mar; 135():111205. PubMed ID: 33395603
[TBL] [Abstract][Full Text] [Related]
17. Targeting cell death.
Hausenloy DJ; Scorrano L
Clin Pharmacol Ther; 2007 Oct; 82(4):370-3. PubMed ID: 17851576
[TBL] [Abstract][Full Text] [Related]
18. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Lu N; Sun Y; Zheng X
Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Oxidative Phosphorylation Function and Mitophagy in Ischaemic/Reperfused Hearts from Control and High-Fat Diet Rats: Effects of Long-Term Melatonin Treatment.
Dhanabalan K; Mzezewa S; Huisamen B; Lochner A
Cardiovasc Drugs Ther; 2020 Dec; 34(6):799-811. PubMed ID: 32458321
[TBL] [Abstract][Full Text] [Related]
20. Mff-Dependent Mitochondrial Fission Contributes to the Pathogenesis of Cardiac Microvasculature Ischemia/Reperfusion Injury via Induction of mROS-Mediated Cardiolipin Oxidation and HK2/VDAC1 Disassociation-Involved mPTP Opening.
Zhou H; Hu S; Jin Q; Shi C; Zhang Y; Zhu P; Ma Q; Tian F; Chen Y
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
